The University of Texas Health Science Center at Tyler
The University of Texas Health Science Center at Tyler
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin | Chemically-Induced Disorders, Drug-Induced Ototoxicity, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, Neurologic Manifestations, Ototoxicity, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, injury, nervous system disorder, otorhinolaryngologic disease, radiation injury | Recruiting | Phase 2 | 2026-10-01 | NCT05730283 | |
| Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, Mycobacterium Infections, Nontuberculous, Mycobacterium avium complex disease, bacterial infectious disease, gram-positive bacterial infections, mycobacterial infectious disease | Active, not recruiting | Phase 2 | 2026-05-06 | NCT02968212 | |
| Irrisept in Emergency General Surgery Patients | Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Surgical Wound Infection, Wound Infection | Enrolling by invitation | Phase 4 | 2025-07-03 | NCT07048899 |